RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
194 hedge funds and large institutions have $3.75B invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2021 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 69 increasing their positions, 66 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
194
Holders Change
-7
Holders Change %
-3.48%
% of All Funds
3.39%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.12%
New
34
Increased
69
Reduced
66
Closed
40
Calls
$30.4M
Puts
$54.7M
Net Calls
-$24.3M
Net Calls Change
-$9.22M
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
$398M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
$106M |
| 3 |
BlackRock
New York
|
$302M |
| 4 |
State Street
Boston,
Massachusetts
|
$83.4M |
| 5 |
Northern Trust
Chicago,
Illinois
|
$40.9M |
